<?xml version='1.0' encoding='utf-8'?>
<document id="16238912"><sentence text="The Q-T interval and antimuscarinic drugs." /><sentence text="Antimuscarinic drugs form the mainstay of pharmacotherapy for the treatment of overactive bladder" /><sentence text=" The primary sites of activity of the agents for the desired therapeutic effect are the M3 and M2 receptors of the bladder" /><sentence text=" Drug interaction with other non-vesical muscarinic receptors produces a range of undesired adverse events" /><sentence text=" In general, certain adverse effects associated with antimuscarinic agents such as dry mouth (salivary) and constipation (colon) may be considered only bothersome, and somnolence and confusion (central nervous system) may be considered more serious in nature" /><sentence text=" However, effects on the myocardium are considered to be more significant safety issues and increased awareness and understanding of the effect of drugs on the myocardium, including the additional effects of drug-drug interaction, has increased a need for the evaluation of new drugs for cardiac safety" /><sentence text=" The role of genetics (and the identification of populations at risk) in the causation of congenital dysrhythmias has received specific attention in this area" /><sentence text=" New drugs now must undergo more intense scrutiny and cardiac testing to evaluate their effects on cardiac rate and rhythm, especially the QT interval" /><sentence text=" The recently approved agents (trospium, solifenacin, darifenacin) used for the treatment of overactive bladder have been rigorously evaluated for these effects"><entity charOffset="31-39" id="DDI-PubMed.16238912.s9.e0" text="trospium" /><entity charOffset="41-52" id="DDI-PubMed.16238912.s9.e1" text="solifenacin" /><entity charOffset="54-65" id="DDI-PubMed.16238912.s9.e2" text="darifenacin" /><pair ddi="false" e1="DDI-PubMed.16238912.s9.e0" e2="DDI-PubMed.16238912.s9.e0" /><pair ddi="false" e1="DDI-PubMed.16238912.s9.e0" e2="DDI-PubMed.16238912.s9.e1" /><pair ddi="false" e1="DDI-PubMed.16238912.s9.e0" e2="DDI-PubMed.16238912.s9.e2" /><pair ddi="false" e1="DDI-PubMed.16238912.s9.e1" e2="DDI-PubMed.16238912.s9.e1" /><pair ddi="false" e1="DDI-PubMed.16238912.s9.e1" e2="DDI-PubMed.16238912.s9.e2" /></sentence><sentence text="" /></document>